SCHEMBL1504429

SCHEMBL1504429

N=CCNCCC[C@H](N)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 2/20 0.46
OTC P00480 1/20 0.45
DDAH1 O94760 3/20 0.42
ARG2 P78540 4/20 0.42
ARG1 P05089 3/20 0.42
NOS2 P35228 2/20 0.41
CYP1A2 P05177 2/20 0.41
GLA P06280 1/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
APEX1 P27695 1/20 0.41
CYP2C19 P33261 1/20 0.41
NOS3 P29474 2/20 0.40
NOS1 P29475 2/20 0.40
GRM8 O00222 1/20 0.39
GRM6 O15303 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIK1 P39086 1/20 0.39
GRM5 P41594 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21067514 1.00 GSR (0.46) GSROTCDDAH1ARG2ARG1
SCHEMBL4316097 1.00 GSR (0.46) GSROTCDDAH1ARG2ARG1
Hydrochloric Acid SCHEMBL8186576 0.98 GSR (0.44) GSROTCDDAH1ARG2ARG1
Hydrochloric Acid SCHEMBL4057533 0.98 GSR (0.44) GSROTCDDAH1ARG2ARG1
Hydrochloric Acid SCHEMBL8900288 0.98 GSR (0.44) GSROTCDDAH1ARG2ARG1
SCHEMBL7974900 0.95 GSR (0.48) GSROTCDDAH1ARG2ARG1
SCHEMBL934762 0.95 GSR (0.48) GSROTCDDAH1ARG2ARG1
Hydrochloric Acid SCHEMBL4581849 0.93 GSR (0.47) GSROTCDDAH1ARG2ARG1
Hydrochloric Acid SCHEMBL7974008 0.93 GSR (0.47) GSROTCDDAH1ARG2ARG1
Hydrochloric Acid SCHEMBL7977023 0.93 GSR (0.47) GSROTCDDAH1ARG2ARG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230440-A1 COMPOSITIONS AND METHODS FOR NEURONAL DIFFERENTIATION OF CELLS Northern Sydney Local Health District (AU) 2017-10-18 EP claimed
WO-2016090408-A1 COMPOSITIONS AND METHODS FOR NEURONAL DIFFERENTIATION OF CELLS NORTHERN SYDNEY LOCAL HEALTH DISTRICT (AU) 2016-06-16 WO claimed
EP-2539434-A1 GAMETES SEPARATION METHODS, COMPOSITIONS AND USES THEREOF Assistance Publique - Hôpitaux de Paris (FR) 2013-01-02 EP claimed
WO-2012106469-A2 METHODS FOR TREATING INFECTIONS BY TARGETING MICROBIAL H2S-PRODUCING ENZYMES NEW YORK UNIVERSITY (US) 2012-08-09 WO claimed
WO-2011032000-A2 METHOD FOR PROTECTION OF ANTIMICROBIAL AND ANTICANCER DRUGS FROM INACTIVATION BY NITRIC OXIDE NEW YORK UNIVERSITY (US) 2011-03-17 WO claimed
WO-2008080194-A1 PAIN-RELIEVING COMPOSITIONS AND USES THEREFOR THE UNIVERSITY OF QUEENSLAND (AU) 2008-07-10 WO claimed
WO-1995028081-A1 ADDRESSING BAIT AVERSION BY DISRUPTING ASSOCIATIVE LEARNING THE MEAT INDUSTRY RESEARCH INSTITUTE OF NEW ZEALAND INC. (NZ) 1995-10-26 WO claimed
EP-4709378-A1 COMPOUNDS FOR NOS-RELATED CANCERS AND METHODS OF USE Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) 2026-03-18 EP disclosed
WO-2024231899-A1 COMPOUNDS FOR NOS-RELATED CANCERS AND METHODS OF USE YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-11-14 WO disclosed
EP-3681504-B1 METHODS OF DETECTION USING X-RAY FLUORESCENCE ICAGEN INC (US) 2023-08-23 EP disclosed
US-11573224-B2 Methods of detection using X-ray fluorescence ICAGEN, LLC (US) 2023-02-07 US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-10877035-B2 Advanced drug development and manufacturing ICAGEN, LLC (US) 2020-12-29 US disclosed
EP-1280526-A1 COMPOSITION FOR THE PREVENTION AND/OR TREATMENT, IN NEWBORN BABIES, OF THE EFFECTS OF COMPLICATIONS DURING CHILDBIRTH Universitair Medisch Centrum Utrecht (NL) 2003-02-05 EP disclosed
WO-2001074351-A1 COMPOSITION FOR THE PREVENTION AND/OR TREATMENT, IN NEWBORN BABIES, OF THE EFFECTS OF COMPLICATIONS DURING CHILDBIRTH UNIVERSITAIR MEDISCH CENTRUM (NL) 2001-10-11 WO disclosed
EP-0751930-B1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-01-05 EP disclosed
EP-0751930-A1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1997-01-08 EP disclosed
WO-1995025717-A1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1995-09-28 WO disclosed
EP-0618898-A1 AMIDINO DERIVATIVES AND THEIR USE AS NITRIC OXIDE SYNTHASE INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1994-10-12 EP disclosed
WO-1993013055-A1 AMIDINO DERIVATIVES AND THEIR USE AS NITRIC OXIDE SYNTHASE INHIBITORS THE WELLCOME FOUNDATION LIMITED (GB) 1993-07-08 WO disclosed